FDA faces Vandaâs ire as it rejects firmâs gastroparesis drug application
Vanda Pharmaceuticals Incâs gastroparesis drug to treat a serious stomach condition was rejected by the Food and Drug Administration (FDA), which asked for.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Vanda Pharmaceuticals Incâs gastroparesis drug to treat a serious stomach condition was rejected by the Food and Drug Administration (FDA), which asked for.
Israelâs Teva Pharmaceuticals has sued US-based Corcept Therapeutics and Optime Care Inc., a specialty pharma, for monopolising the market for a drug used to.
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit